Rallybio Corporation (RLYB) Financial Ratios
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
RLYB stock: frequently asked questions
What is RLYB's ST Score?
Rallybio Corporation (RLYB) has an ST Score of 63.7 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is RLYB a buy, hold, or sell?
Analysts rate RLYB a Hold. Our ST Score grades it B (63.7/100). The ST Score is a data-driven signal, not a recommendation.
What are RLYB's factor grades?
Valuation D, Profitability A, Financial Strength A+, Momentum A+, Growth C-.
What is RLYB's valuation grade?
Rallybio Corporation (RLYB) earns a valuation grade of D, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is RLYB's growth grade?
Rallybio Corporation (RLYB) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is RLYB's profitability grade?
Rallybio Corporation (RLYB) earns a profitability grade of A, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is RLYB's financial strength grade?
Rallybio Corporation (RLYB) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is RLYB's Piotroski score?
Rallybio Corporation (RLYB) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.